Trial register facet
Trial records in cutaneous wound healing and tissue repair
30 records bearing on cutaneous wound healing and tissue repair.
Showing 0 records on this page
Records
30 documents · page 1 of 2
Table 1. Trial records on this page. The table sorts on any column and filters on the controls above; both operate on the records shown on this page only.
| Record | Compound | Phase | Status | Design | Randomised | Year | Certainty |
|---|---|---|---|---|---|---|---|
| TB4-PH2-EPIDERMOLYSIS | Thymosin beta-4 | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | 30 | 2016 | Low |
| TB4-PH2-EPIDERMOLYSIS-REGIONAL-JPprogramme record | Thymosin beta-4 | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | 2016 | Very low |
| TB4-PH2-EPIDERMOLYSIS-BODY-COMPprogramme record | Thymosin beta-4 | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 2016 | Very low |
| TB4-PH2-EPIDERMOLYSIS-QOLprogramme record | Thymosin beta-4 | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 2016 | Very low |
| TB4-PH2-EPIDERMOLYSIS-REGIONAL-CNprogramme record | Thymosin beta-4 | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | 2016 | Very low |
| TB4-PH2-DRYEYE | Thymosin beta-4 | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | 72 | 2015 | Low |
| TB4-PH2-DRYEYE-ELDERLYprogramme record | Thymosin beta-4 | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 2015 | Very low |
| TB4-PH2-DRYEYE-OLEprogramme record | Thymosin beta-4 | Phase 2 | Reported | Single-arm open-label | — | 2015 | Very low |
| TB4-PH2-DRYEYE-ADHERENCEprogramme record | Thymosin beta-4 | Phase 2 | Reported | Observational | — | 2015 | Very low |
| TB4-PH2-DRYEYE-BIOMARKERprogramme record | Thymosin beta-4 | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 2015 | Very low |
| LL37-PH1-2-VENOUSULCER | LL-37 | Phase 1/2 | Reported | Randomised, double-blind, placebo-controlled | 34 | 2014 | Low |
| LL37-PH1-2-VENOUSULCER-QOLprogramme record | LL-37 | Phase 1/2 | Reported | Randomised, double-blind, placebo-controlled | — | 2014 | Very low |
| LL37-PH1-2-VENOUSULCER-REGIONAL-CNprogramme record | LL-37 | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | 2014 | Very low |
| LL37-PH1-2-VENOUSULCER-REGIONAL-JPprogramme record | LL-37 | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | 2014 | Very low |
| LL37-PH1-2-VENOUSULCER-BODY-COMPprogramme record | LL-37 | Phase 1/2 | Reported | Randomised, double-blind, placebo-controlled | — | 2014 | Very low |
| TB4-PH2-VENOUSULCER | Thymosin beta-4 | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | 72 | 2013 | Low |
| TB4-PH2-VENOUSULCER-OLEprogramme record | Thymosin beta-4 | Phase 2 | Reported | Single-arm open-label | — | 2013 | Very low |
| TB4-PH2-VENOUSULCER-ELDERLYprogramme record | Thymosin beta-4 | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 2013 | Very low |
| TB4-PH2-VENOUSULCER-BIOMARKERprogramme record | Thymosin beta-4 | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 2013 | Very low |
| TB4-PH2-VENOUSULCER-ADHERENCEprogramme record | Thymosin beta-4 | Phase 2 | Reported | Observational | — | 2013 | Very low |
| GHKCU-TOPICAL-2 | GHK-Cu | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 2007 | Low |
| GHKCU-TOPICAL-2-HEPATIC-IMPprogramme record | GHK-Cu | Phase 1 | Reported | Phase 1 ascending dose | — | 2007 | Very low |
| GHKCU-TOPICAL-2-DDIprogramme record | GHK-Cu | Phase 1 | Reported | Randomised crossover | — | 2007 | Very low |
| GHKCU-TOPICAL-2-PKprogramme record | GHK-Cu | Phase 1 | Reported | Phase 1 ascending dose | — | 2007 | Very low |
page 1 of 2